A VALIDATED STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF NIRMATRELVIR AND RITONAVIR IN BULK DRUG AND MARKETED PHARMACEUTICAL DOSAGE FORMS
A rapid and precise reverse phase high performance liquid chromatographic method has been developed for the validated of Nirmatrelvir and Ritonavir, in its pure form as well as in marketed pharmaceutical dosage forms. This Chromatographic Separation was carried out on Develosil C18 (4.6mm×250mm) 5µm particle size Column using a mixture of Acetonitrile and Acetate buffer (pH-4.3) was taken in the ratio of 35:65% v/v as the mobile phase at a flow rate of 1.0 mL/min, the wavelength detection was carried out at 238nm. The retention time of the Nirmatrelvir and Ritonavir was found to be 2.179, 3.610 ± 0.02 min respectively. The method produce linear responses in the concentration range of 20-60µg/ml of Nirmatrelvir and 10-30µg/ml of Ritonavir respectively. The developed method precision for the determination of assay was below 2.0%RSD. The developed method is useful in the quality control of bulk and pharmaceutical formulations.
Authors
- H. Ramana
- P. Laxmi Madhuri
- Singam Vinisha
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.5281/zenodo.24216351
- Primary Topic
- Analytical Methods in Pharmaceuticals
- Type
- article
- Field-Weighted Citation Impact
- 0.00